Le Grand Témoin -

Mark Pearson


Propos recueillis par : P. Garassus | Ecrit le 14/02/11 | envoyer l'article par mail envoyer par mail | impression Imprimer | Document Joint

France marked OCDE 50th anniversary on December, 13 2010 : may we have a summary on a long history concerning health care systems studies by OECD ?
Mark Pearson :

"The OECD might be 50 years old, but it has not been working on health policy for all this time. Until relatively recently, ‘health’ was seen as somehow nothing to do with the economy. Only in the past two decades has the economic importance of health been recognized. After all, health now accounts for over 9% of GDP in OECD countries, and in the 15 years before the financial crisis was increasing at 3 times the rate of GDP as a whole. Over 10% of employment is in the health sector. OECD work focused first of all on developing better statistics so that we could compare health systems across countries, and over the past decade we have looked at ‘what works’ in improving health system performance."

The publication “Health at a glance” is a major source of international information. How works OECD on this topic ?
MP :

"It is not, unfortunately, a case of simply asking countries to give us their information. Nothing in health is easy to define. What is a hospital ? This is very difficult to answer. Definitions of ‘nurses’ vary hugely across countries. Most health spending is easy to recognize, but is a school-based programme on improving nutrition part of health care or not ? We can only make sense of international comparisons if countries agree on definitions first. And this can take years to achieve. But once countries really do agree that they really are comparing ‘apples with apples’ and not ‘apples with pears’, then statistics are the best way of persuading countries that they need to change policies. "

Comparison of healthcare goods and services : what’s new ?
MP :

"Despite all the efforts that have been made by so many people and organizations over the years, we still know far less about how health systems really work than we should. Anyone who wants to get a good idea about pay levels (and even numbers of workers) in health systems will quickly get frustrated. And this is one of the areas which policymakers are beginning to get very anxious about. A series of strikes and protests in Eastern Europe have shown that pay in the health sector can lead to real crises, not to mention the tensions caused by migration between developing and developed countries of trained health care staff."

Better value for money in health care : “how to spend it” efficiently ? Could quality indicators enhance the value ?
MP :

"Most health workers are suspicious about calls for ‘value for money’ in health spending. They believe it to be code for cuts. But it does not need to be : more quality for the same money is often far more achievable as a goal for health reformers than reducing spending. Understanding what we get for our health money is the first step here. Quality indicators can move policy – the effect of poor cancer survival rates had a huge effect on UK policy. At the moment, there is massive interest in variations in medical practice. Country after country is coming up with evidence that the difference between the best and worst performing health institutions is almost unbelievably high – far bigger than any differences in the standard of care across countries. Improve the worst performers to match the average, and the improvements in value for money would be amazing."

Financial crisis : few easy solutions for Healthcare policies too ?
MP :

"For a while, many people thought health spending would not be affected by the crisis, but reality has not hit. Generally, most countries have handled reductions in spending (or in the rate of growth of spending) better this time than in previous crises. Ministers have tried to protect access and quality of care, and prevention spending has hardly been touched. Instead they have tried to reduce salaries ; have deferred investment ; and have reformed pharmaceutical policies. Most patients have not been affected by these changes. However, there are limits to such policies. In several countries, any further cuts will start to damage health systems."


Ecrit le 14/02/11 | envoyer l'article par mail envoyer par mail | impression Imprimer | Document Joint

Grands Témoins

JL HAROUSSEAU

Paul GARASSUS, SFES (PG) – Quel positionnement (...)

Lire la suite >

Daniel BAHR

Traduction Française disponible ici . (...)

Lire la suite >

Daniel BAHR

Interview en VO(allemand) disponible ici . (...)

Lire la suite >

Hirotoshi Nishizawa

Les hopitaux japonais après le tremblement de (...)

Lire la suite >

Mark Pearson

Chef de la division santé OCDE

Lire la suite >

Séminaire JEM SFES : Introduction aux outils statistiques bayésiens.

Tirer parti de toute l’information en Economie de la Santé Dans le (...)

Lire la suite >

Les événements de l’année en Economie Médicale. Paris 27 Janvier (...)

PROGRAMME 9h00 - 9h30 ACCUEIL 9h30 - 12h00 conférenciers invités (...)

Lire la suite >

Making globalisation socially sustainable

Téléchargez le dossier complet en "Document joint"

Lire la suite >

IMF Working paper The Eurozone crisis

Téléchargez le document complet en pièce jointe

Lire la suite >

Health Professional Mobility and Health Systems

Téléchargez le rapport complet en "Document joint"

Lire la suite >

Séminaire Lyon, 5 - 7 Janvier 2012

Programme Jeudi 5 janvier 2012 : Politiques de santé : acteurs, (...)

Lire la suite >

Seminaire JEM-SFES - Tirer parti de toute l’information en Économie de la (...)

Tirer parti de toute l’information en Économie de la santé (...)

Lire la suite >

Rencontres annuelles des decideurs de l’industrie pharmaceutique

Lire la suite >

Colloque, Pharmaciens, Assurances santé, et Services Pharmaceutiques (...)

Mercredi 22 juin 2011 colloque : Pharmaciens, Assurances santé, et (...)

Lire la suite >

Evaluation et prix des technologies médicales France - États Unis

Secteur fortement innovant, les technologies médicales apportent (...)

Lire la suite >

Biotechnologie, France Etats-Unis évolution ou transformation du marché (...)

La croissance des dépenses médicaments à l’hôpital est tirée par les (...)

Lire la suite >

Les hôpitaux et l’investissement.

Présentation par l’éditeur Le patrimoine hospitalier est vieux de (...)

Lire la suite >

Il faut sauver le patient Adam Smith

Les descendants de nos deux philosophes voient le système de santé (...)

Lire la suite >

The economist "Economist Conferences" Genève 17 mars 2011

"Europe Healthcare systems are at critical juncture. With (...)

Lire la suite >

XXIVe Congrès National ÉMOIS 2011

Programme des journées ÉMOIS 2011 - Les 17 et 18 mars (...)

Lire la suite >